Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.490
-0.090 (-5.70%)
Dec 26, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.01 million as of December 26, 2025. Its market cap has decreased by -18.70% in one year.
Market Cap
3.01M
Enterprise Value
2.24M
1-Year Change
-18.70%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $3.01M, a decrease of -75.55%. That is a compound annual growth rate of -19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 3.20M | -5.88% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.34B |
| Johnson & Johnson | 499.83B |
| AbbVie | 407.51B |
| UnitedHealth Group | 296.67B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 263.86B |
| Novo Nordisk | 232.28B |